人工耳蜗植入12个月后功能能力改善相关的CIQOL-35 Profile条件最小可检测变化值
该研究基于705名CI用户的多机构队列,采用项目反应理论推导CIQOL-35各领域评分的标准误,进而计算条件最小可检测变化(cMDC)值,并在65名成人CI用户独立队列中比较术前与术后12个月评分,发现60人(92.3%)至少一个领域改善超过cMDC,无患者任何领域评分下降超过cMDC。
要点
- CIQOL-35各领域cMDC值在量表极端处更大,沟通领域和全局测量的cMDC值较小。
- 术后12个月,60名(92.3%)CI用户至少一个领域改善超过cMDC,无患者任何领域下降超过cMDC。
- 改善超过cMDC的比例因领域而异,沟通领域53人(81.5%)最多,全局42人(64.6%),娱乐40人(60.9%)。
核心结论
- CIQOL-35 Profile的cMDC值为检测患者自报功能能力随时间发生的真实变化提供了个性化阈值,可能有助于临床决策。
- 纵向结果揭示了改善程度不同的领域,可能有助于患者咨询。
研究设计与样本
- 对705名CI用户的多机构队列进行项目反应理论分析,采用迭代方法计算所有可能的术前和术后领域评分组合的cMDC值。
- 在65名成人CI用户的独立队列中比较术前与术后12个月CIQOL-35领域评分,以确定变化是否超过误差而具有临床意义。
- 分析于2022年12月14日进行。
主要发现
- cMDC值在沟通领域和全局测量中较小,所有领域的cMDC值在测量量表极端处更大。
- 术后12个月,60名CI用户(92.3%)至少一个CIQOL-35领域改善超过cMDC,无患者任何领域评分下降超过cMDC。
- 改善超过cMDC的比例因领域而异:沟通领域53人(81.5%),全局42人(64.6%),娱乐40人(60.9%)。
- 总体上,CIQOL-35领域改善的CI用户言语识别评分改善更大,但关联强度和显著性因领域和言语材料而异。
关键数值与推荐
- cMDC值针对CIQOL-35 Profile各领域评分,在量表极端处更大,沟通领域和全局测量较小。
- 术后12个月至少一个领域改善超过cMDC的CI用户为60/65(92.3%)。
- 沟通领域改善超过cMDC的CI用户为53/65(81.5%),全局为42/65(64.6%),娱乐为40/65(60.9%)。
临床怎么用
- cMDC值可为临床决策提供个性化阈值,以检测患者自报功能能力的真实变化。
- 纵向结果揭示的改善程度不同的领域可能有助于患者咨询。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: It is essential to measure an individual patient's baseline and follow-up abilities to demonstrate changes in clinical outcomes over time. Inherent in this strategy is interpreting whether the measured change is clinically significant and beyond measurement error. Conditional minimal detectable change (cMDC) values are widely used in many disciplines but have rarely been established for outcome measures in otolaryngology or hearing research, and never in cochlear implantation. OBJECTIVE: To determine cMDC values for the Cochlear Implant Quality of Life-35 (CIQOL-35) Profile instrument to enhance our understanding of the initial and ongoing changes in functional abilities from cochlear implants (CIs). DESIGN, SETTING, AND PARTICIPANTS: Item response theory analyses of responses from a multi-institutional cohort of 705 CI users at a tertiary CI center were used to derive standard error (SE) values for each possible CIQOL-35 domain score. Using an iterative approach, these SE values were used to calculate cMDC values for every possible pre-CI and post-CI domain score combination. We then compared pre-CI to 12-month post-CI CIQOL-35 domains scores in an independent cohort of 65 adult CI users to determine whether the measured change exceeded error to be clinically significant. The analysis took place on December 14, 2022. INTERVENTIONS: The CIQOL-35 Profile instrument and cochlear implantation. RESULTS: The cMDC values were smaller for the communication domain, and global measure and cMDC values for all domains were larger at the extremes of the measurement scale. Overall, 60 CI users (92.3%) demonstrated improvement beyond cMDC at 12 months post-CI for at least 1 CIQOL-35 domain, and no patients' scores declined beyond cMDC for any domain. The percentage of CI users demonstrating improvement beyond cMDC varied by domain, with communication (53 [81.5%]) showing the largest number of CI users improving, followed by global (42 [64.6%]) and entertainment (40 [60.9%]). In general, CI users who demonstrated improvement in CIQOL-35 domains had greater improvement in speech recognition scores than patients who did not, but the strength and significance of these associations greatly varied by domain and speech material. CONCLUSIONS AND RELEVANCE: This multistep cohort study found that cMDC values for the CIQOL-35 Profile provided personalized thresholds for detecting real changes in patient self-reported functional abilities over time across multiple domains, which may inform clinical decision-making. Moreover, these longitudinal results reveal the domains with more or less improvement, which may aid in patient counseling.
引用
- McRackan TR, Seamon BA, Shannon CM, et al. Conditional Minimal Detectable Change for the Cochlear Implant Quality of Life-35 Profile Associated With Improved Functional Abilities 12 Months After Cochlear Implantation. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 37318794. doi:10.1001/jamaoto.2023.1090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。